Citigroup’s Candel Therapeutics CADL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $70.5K | Sell |
13,935
-6,303
| -31% | -$31.9K | ﹤0.01% | 3860 |
|
|
2025
Q1 | $114K | Buy |
20,238
+1,635
| +9% | +$9.24K | ﹤0.01% | 3755 |
|
|
2024
Q4 | $161K | Buy |
18,603
+4,113
| +28% | +$35.7K | ﹤0.01% | 3710 |
|
|
2024
Q3 | $100K | Buy |
14,490
+9,892
| +215% | +$68.6K | ﹤0.01% | 3989 |
|
|
2024
Q2 | $28.5K | Buy |
+4,598
| New | +$28.5K | ﹤0.01% | 4150 |
|
|
2023
Q3 | – | Sell |
-118,612
| Closed | -$149K | – | 4884 |
|
|
2023
Q2 | $149K | Buy |
+118,612
| New | +$149K | ﹤0.01% | 3372 |
|
|
2023
Q1 | – | Sell |
-352
| Closed | -$630 | – | 4753 |
|
|
2022
Q4 | $630 | Buy |
352
+17
| +5% | +$30 | ﹤0.01% | 4681 |
|
|
2022
Q3 | $1K | Sell |
335
-95
| -22% | -$284 | ﹤0.01% | 4778 |
|
|
2022
Q2 | $1K | Sell |
430
-180
| -30% | -$419 | ﹤0.01% | 5175 |
|
|
2022
Q1 | $3K | Sell |
610
-256
| -30% | -$1.26K | ﹤0.01% | 5120 |
|
|
2021
Q4 | $7K | Buy |
+866
| New | +$7K | ﹤0.01% | 4836 |
|